Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +4.65% | -15.62% | +18.42% |
Evolution of the average Target Price on NextCure, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering NextCure, Inc.
HC Wainwright | |
Piper Sandler | |
Ladenburg Thalmann | |
Roth Capital Partners | |
Needham & Co. | |
BTIG | |
Truist Securities | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- NXTC Stock
- Consensus NextCure, Inc.